According to Foresight News , YZi Labs issued a statement saying it is reviewing CEA Industries' response to YZi Labs' written consent solicitation process. These actions include employing a poison pill plan and amending the company's articles of incorporation, aimed at thwarting and delaying shareholders' exercise of their rights. YZi Labs believes the board's aim is to consolidate its own position and has already postponed its 2025 annual meeting until after the anniversary date of December 17th.
Furthermore, YZi Labs refuted CEA Industries' claim that it had never considered an alternative token strategy, pointing out that its CEO, David Namdar, explicitly stated at an industry conference in November 2025 that it was considering switching to assets such as Solana. YZi Labs urged its board to refrain from further actions and to ensure a fair nomination and election process for directors.
